It is thus not surprising that different compounds, including both natural substances and synthetic chemicals, acting by promoting Nrf2 preventive activity are currently considered as promising anti-tumour agents and some of them are already used in clinical trials for different types of cancer. Here, NFE2L2 is linked to cancer.